DEA schedule
Is glycopyrrolate a controlled substance?
Federal schedule for glycopyrrolate from the FDA NDC directory, checked against the DEA controlled substances list.
Source: FDA NDC Directory file dated 2026-10-22. Publisher page
No. Glycopyrrolate is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and glycopyrrolate is not on the DEA controlled substances list.
Run it in Rivvi
Which 2027 plans near you dropped or restricted glycopyrrolate?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Schedule check
| Source | What it lists |
|---|---|
| FDA NDC directory | 193 prescription listings from 62 labelers, none with a DEA schedule |
| DEA controlled substances list | glycopyrrolate is not on the list |
Glycopyrrolate NDC listings
| NDC | Product | Form | Strength | Labeler | DEA schedule |
|---|---|---|---|---|---|
| 0259-0501 | Cuvposa | liquid | 1 mg/5mL | Merz Pharmaceuticals, LLC | None |
| 0641-6212 | Glycopyrrolate | injection | .2 mg/mL | Hikma Pharmaceuticals USA Inc. | None |
| 0641-6213 | Glycopyrrolate | injection | .2 mg/mL | Hikma Pharmaceuticals USA Inc. | None |
| 76045-023 | Glycopyrrolate | injection | .2 mg/mL | Fresenius Kabi USA, LLC | None |
| 76045-223 | Glycopyrrolate | injection | .2 mg/mL | Fresenius Kabi USA, LLC | None |
| 51754-6000 | GLYRX-PF | injection, solution | .2 mg/mL | Exela Pharma Sciences, LLC | None |
| 51754-6001 | GLYRX-PF | injection, solution | .2 mg/mL | Exela Pharma Sciences, LLC | None |
| 51754-6013 | GLYRX-PF | injection, solution | .2 mg/mL | Exela Pharma Sciences, LLC | None |
| 51754-6015 | GLYRX-PF | injection, solution | .2 mg/mL | Exela Pharma Sciences, LLC | None |
| 80056-160 | Glycate | tablet | 1.5 mg/1 | Intra-Sana Laboratories | None |
| 0143-9584 | Glycopyrrolate | injection | .2 mg/mL | Hikma Pharmaceuticals USA Inc. | None |
| 0143-9585 | Glycopyrrolate | injection | .2 mg/mL | Hikma Pharmaceuticals USA Inc. | None |
| 0143-9586 | Glycopyrrolate | injection | .2 mg/mL | Hikma Pharmaceuticals USA Inc. | None |
| 0143-9587 | Glycopyrrolate | injection | .2 mg/mL | Hikma Pharmaceuticals USA Inc. | None |
| 0143-9679 | Glycopyrrolate | injection | .2 mg/mL | Hikma Pharmaceuticals USA Inc. | None |
| 0143-9680 | Glycopyrrolate | injection | .2 mg/mL | Hikma Pharmaceuticals USA Inc. | None |
| 0143-9681 | Glycopyrrolate | injection | .2 mg/mL | Hikma Pharmaceuticals USA Inc. | None |
| 0143-9682 | Glycopyrrolate | injection | .2 mg/mL | Hikma Pharmaceuticals USA Inc. | None |
| 0781-3825 | Glycopyrrolate | injection | .2 mg/mL | Sandoz Inc | None |
| 16729-471 | Glycopyrrolate | injection | .2 mg/mL | Accord Healthcare, Inc., | None |
| 16729-472 | Glycopyrrolate | injection | .2 mg/mL | Accord Healthcare, Inc., | None |
| 16729-473 | Glycopyrrolate | injection | .2 mg/mL | Accord Healthcare, Inc., | None |
| 16729-474 | Glycopyrrolate | injection | .2 mg/mL | Accord Healthcare, Inc., | None |
| 43547-543 | GLYCOPYRROLATE | injection | .2 mg/mL | Solco Healthcare US, LLC | None |
| 43547-639 | GLYCOPYRROLATE | injection | .2 mg/mL | Solco Healthcare US, LLC | None |
| 51662-1425 | GLYCOPYRROLATE | injection | .2 mg/mL | HF Acquisition Co LLC, DBA HealthFirst | None |
| 51662-1484 | GLYCOPYRROLATE | injection | .2 mg/mL | HF Acquisition Co LLC, DBA HealthFirst | None |
| 51662-1487 | GLYCOPYRROLATE | injection | .2 mg/mL | HF Acquisition Co LLC, DBA HealthFirst | None |
| 51662-1554 | GLYCOPYRROLATE | injection | .2 mg/mL | HF Acquisition Co LLC, DBA HealthFirst | None |
| 51662-1601 | GLYCOPYRROLATE | injection | .2 mg/mL | HF Acquisition Co LLC, DBA HealthFirst | None |
| 55154-7475 | Glycopyrrolate | injection | .2 mg/mL | Cardinal Health 107, LLC | None |
| 62332-607 | Glycopyrrolate | injection | .2 mg/mL | Alembic Pharmaceuticals Inc. | None |
| 62332-627 | Glycopyrrolate | injection | .2 mg/mL | Alembic Pharmaceuticals Inc. | None |
| 62332-628 | Glycopyrrolate | injection | .2 mg/mL | Alembic Pharmaceuticals Inc. | None |
| 62332-629 | Glycopyrrolate | injection | .2 mg/mL | Alembic Pharmaceuticals Inc. | None |
| 65145-102 | Glycopyrrolate | injection | .2 mg/mL | Caplin Steriles Limited | None |
| 68083-376 | Glycopyrrolate | injection | .2 mg/mL | Gland Pharma Limited | None |
| 68083-377 | Glycopyrrolate | injection | .2 mg/mL | Gland Pharma Limited | None |
| 68083-378 | Glycopyrrolate | injection | .2 mg/mL | Gland Pharma Limited | None |
| 68083-379 | Glycopyrrolate | injection | .2 mg/mL | Gland Pharma Limited | None |
Showing 40 of 193 listings.
Questions
Is glycopyrrolate a controlled substance?
No. Glycopyrrolate is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and glycopyrrolate is not on the DEA controlled substances list.
Is glycopyrrolate a narcotic?
No. Glycopyrrolate is not on the DEA controlled substances list, so the DEA does not classify it as a narcotic. Its FDA established pharmacologic class is Anticholinergic and Cholinergic Muscarinic Antagonist.
Does this page cover state schedules?
No. This page reports the federal schedule only. Some states schedule drugs on their own; check your state board of pharmacy.
More on Glycopyrrolate
- What is Glycopyrrolate used for?FDA label uses
- Generic for RobinulFDA Orange Book
- Generic for Glyrx-pfFDA Orange Book
- Generic for CuvposaFDA Orange Book
- Generic for Robinul ForteFDA Orange Book
- Anticholinergics listFDA drug class
- Cholinergic Muscarinic Antagonists listFDA drug class
- NDC 0259-0501Glycopyrrolate NDC record
- NDC 0641-6212Glycopyrrolate NDC record
- NDC 0641-6213Glycopyrrolate NDC record